Searched for
ARAGEN
ET AI Awards & Conclave 2025: Meet the Innovation & Impacts Award winners accelerating AI at scaleThe ET AI Awards & Conclave 2025 recognised high-growth startups and SMEs deploying artificial intelligence (AI) to solve real industry pro...- Quadria Capital weighs Encube sale, keeps public float option alive, tooQuadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...
- Avendus Fund, SBI Life lead funding in AragenAvendus Future Leaders Fund and SBI Life Insurance have collectively invested ₹300 crore in Aragen Life Sciences, acquiring a 2.5% stake in...
- Quadria's third fund nets $1 billion, to deploy 60% in IndiaQuadria Capital, an Asia healthcare-focused private equity firm, has successfully raised $1.07 billion for its third fund, surpassing its i...
- India's contract drug makers seek government support in China fightIndia's contract drug makers are seeking government support to remove regulatory hurdles and speed up raw material import clearances. With ...
- Quadria Capital invests $100 million in Aragen LifeIn this pre-IPO round, Quadria will acquire the minority stake in Aragen, at an approximate valuation of $1.4 bn, primarily through a fresh...
- Quadria Capital to pick up minority stake in drug company AragenQuadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...
- Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keenInvestors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...
- Aragen Life Sciences to invest Rs 2,000 cr for expansion of facility in HyderabadAragen Life Sciences plans to invest Rs 2000 crore in its Hyderabad plant for expansion, creating 1,500 new jobs. The expansion is focused ...
- Indian drug manufacturers benefit from Big Pharma interest beyond ChinaChina has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low ...
- PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...
- GVK's Keshav Reddy bets big on India's Digital Public Infrastructure with ID platform EqualThe platform -- Equal, is built in partnership with government-owned DigiLocker and public digital infrastructure India Stack.
- CRO market still very much untapped in India: Cyndrella CarvalhoIndian CROs and CDMOs are attracting a lot of attention as companies, such as Syngene, Suven, and Divis, create long-term relationships wit...
- FDI in research, development increases to USD 344 mn in 2021: comm minFDI inflows in the research and development sector have increased to USD 343.64 million in 2021 against USD 55.77 million in 2020, the comm...
- Aragen acquires Pune-based pre-clinical research provider IntoxAragen Life Sciences signs a definitive agreement to acquire Pune-based Intox Pvt. Ltd. The Hyderabad-based Aragen, which was formerly call...
- Goldman Sachs buys stake in contract research firm Aragen Life SciencesAragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...
- Goldman Sachs set to buy 33% stake in GVK Bio at Rs 7,300-crore valuationThe other contenders included Carlyle Group, Warburg Pincus, General Atlantic and Quadria Capital, as well as Singapore’s Temasek Holdings.
- Global PE funds eye stake in GVK Bio, co valued at $800 mnIn this proposed transaction, GVK BIO- promoted by the GVK Group and DS Brar, the former CEO and managing director of Ranbaxy Laboratories,...
- GVK Biosciences plans Rs 100 crore active pharmaceutical ingredients facilityGVK Biosciences proposes to set up active pharmaceutical ingredients (APIs) manufacturing facility to cater to the needs of its existing an...
- GVK BIO signs pact with US-based Aragen Bioscience Inc for acquisitionGVK BIO, a leading small-molecule Contract Research Organisation (CRO) today announced that it signed an agreement to acquire Aragen Biosci...
Load More
